Submitted by Anonymous (not verified) on 15 November 2024 - 14:15
Human medicines European public assessment report (EPAR): Celsunax, ioflupane (123I), Date of authorisation: 17/06/2021, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Celsunax, ioflupane (123I), Date of authorisation: 17/06/2021, Revision: 1, Status: Authorised